2025 Upstate Cancer Symposium

Accredited by CineMed.

PROGRAM OVERVIEW

The Upstate Cancer Symposium is a live, in-person meeting designed to empower practicing hematologists and oncologists, advanced practice providers, and fellows with cutting-edge knowledge and practical tools to elevate patient care. The symposium will highlight treatment advances, offering evidence-based insights from clinical trials and registries. The meeting will include discussions between therapeutic area experts and community oncology providers, program polling, slide delivery, and active learning assessments. The format is designed to address current barriers to optimal care for individual patients with cancer. The meeting will cover a broad range of oncology topics, including breast cancer, lung cancer, hematologic malignancies, genitourinary cancers, and gastrointestinal cancers, with a focus on personalized medicine, molecular insights, and collaborative care.

LOCATION

The Atrium

1 Robert Rich Way, Buffalo, NY 14213

DISCLOSURE OF CONFLICTS OF INTEREST

CineMed. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by CineMed. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

A full list of presenter disclosures will be available to all attendees at the live event.

The CineMed. planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

ACCREDITATION INFORMATION

ACCREDITATION STATEMENT

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by CineMed and Oncology Brothers. CineMed is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

• CineMed designates this enduring material for 8.50 AMA PRA Category 1 Credit(s)™.

• Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CREDIT DESIGNATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

TARGET AUDIENCE

The activity is designed for medical oncologists, physician assistants, nurse practitioners, and other health care professionals involved in treating and managing patients with solid tumors and hematologic malignancies in community-based settings.

LEARNING OBJECTIVES

By the conclusion of this symposium, participants will be able to:

1. Select guideline-recommended treatment strategies based on the most recent clinical evidence.

2. Utilize best practices in molecular testing, including selecting appropriate molecular panels and interpreting results, to guide therapy decisions.

3. Incorporate practice-changing data from major congresses such as the 2025 ASCO Annual Meeting to enhance clinical decision-making within the current treatment paradigm.

4. Develop strategies for identifying, managing, and mitigating adverse events associated with targeted therapies and immunotherapies.

5. Foster collaboration among oncology professionals to deliver comprehensive cancer care.

FEE INFORMATION

There is no registration fee for attending this symposium; however, seating is limited. Pre registration does not guarantee seating. We do recommend arriving at the symposium location early.

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc).

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. CineMed. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you register or participate in an educational activity sponsored by CineMed, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and… (continued)

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.